The United States exhibits the highest mortality from bladder malignant neoplasms with a significant margin compared to other countries. The United Kingdom and Germany follow but have notably lower figures. Brazil shows a higher year-on-year increase, alongside South Korea and Costa Rica. Some countries like Portugal and Denmark reflect a decrease in mortality. Mortality rates, generally low across Scandinavia and some South American nations, are on an upward trend, notably in Slovakia and Mexico. Over the last five years, countries have shown varying annual growth rates, demonstrating mixed progress on managing bladder cancer mortality.
Future trends likely include technological advancements in early detection and treatment which could reduce global mortality rates. Population aging and lifestyle changes in developing countries are expected to shape future incidence and mortality patterns. Monitoring healthcare policy implementation, resource allocation, and public health initiatives will be critical to understanding regional variations in mortality trends.
Top countries in Bladder Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 16,740 | 2023 | -0.066% | +0.12% | View data |
| 2 | 2 United Kingdom | 5,780 | 2023 | +0.82% | +1.16% | View data |
| 3 | 3 Germany | 5,720 | 2023 | -0.28% | +0.067% | View data |
| 4 | 4 Brazil | 5,050 | 2023 | +2.54% | +2.66% | View data |
| 5 | 5 Poland | 4,480 | 2023 | +2.19% | +2.42% | View data |
| 6 | 6 Spain | 4,440 | 2023 | -0.27% | +0.18% | View data |
| 7 | 7 Canada | 2,360 | 2023 | +1.11% | +0.46% | View data |
| 8 | 8 Romania | 1,740 | 2023 | +1.22% | +1.77% | View data |
| 9 | 9 South Korea | 1,690 | 2023 | +2.23% | +3.94% | View data |
| 10 | 10 Greece | 1,360 | 2023 | +1.04% | +1.33% | View data |
